Bliss GVS Pharma
BLISSGVS · Pharma > Pharmaceuticals & Drugs · Chairman: S R Vaidya · MD: Gagan Harsh Sharma · Listing date: July 26, 2010 · Employees: 683 · Mumbai · http://www.blissgvs.com

Stock Price vs Company Growth
1d
2.4%
1w
4.7%
1m
9.8%
3m
29.8%
6m
74.6%
1y
135.4%
5y
20.8%
10y
10.4%
all
14.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 282 2.4%
194
293
Company Overview

Sales
927 Cr
Growth: 6.8%
Profit after Tax
129 Cr
Growth: 18.3%
Small Cap
2,983 Cr
P/E: 23.4x
Industry P/E: 30.7x
Fundamentals

Sales (Cr) ₹ 927
Growth 6.8%
EBITDA 16.4%
P/S 3.2x
Dividend 0.5%
P/E 23.4x
Book Value ₹ 113
PEG Ratio 3.5x
ROE 11.3%
P/B 2.5x
Shareholding Pattern

Institutions
Arian Investment Ltd
9.7 %
Life Insurance Corporation Of India
6.68 %
Polus Global Fund
4.62 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
2.9 %
Aspire Emerging Fund
2.46 %
Promoters
Narsimha Shibroor Kamath
33.24 %
Others
Gulbarga Trading And Investment Pvt. Ltd.
5.67 %
Arjun Gautam Ashra
4.89 %
Gautam Rasiklal Ashra
2.82 %
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs
2.2 %
Llp
0.05 %
Increase    Decrease    No change
Company Profile Detailed

It is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception.
Investors (66)
Followers (10)